0001209191-14-075098.txt : 20141212 0001209191-14-075098.hdr.sgml : 20141212 20141212184919 ACCESSION NUMBER: 0001209191-14-075098 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141210 FILED AS OF DATE: 20141212 DATE AS OF CHANGE: 20141212 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anacor Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001411158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 251854385 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1020 E. MEADOW CIRCLE CITY: PALO ALTO STATE: CA ZIP: 94303 BUSINESS PHONE: 650-543-7500 MAIL ADDRESS: STREET 1: 1020 E. MEADOW CIRCLE CITY: PALO ALTO STATE: CA ZIP: 94303 FORMER COMPANY: FORMER CONFORMED NAME: Anacor Pharmaceuticals Inc DATE OF NAME CHANGE: 20070830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shapiro Lucy CENTRAL INDEX KEY: 0001435944 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34973 FILM NUMBER: 141284684 MAIL ADDRESS: STREET 1: 10210 GENETIC CENTER COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-12-10 0 0001411158 Anacor Pharmaceuticals, Inc. ANAC 0001435944 Shapiro Lucy C/O ANACOR PHARMACEUTICALS, INC. 1020 EAST MEADOW CIRCLE PALO ALTO CA 94303 1 0 0 0 Common Stock 2014-12-10 4 M 0 3000 7.25 A 39248 D Common Stock 2014-12-10 4 S 0 3000 35.7864 D 36248 D Common Stock 2014-12-10 4 M 0 834 0.60 A 37082 D Common Stock 2014-12-10 4 S 0 834 35.7864 D 36248 D Common Stock 2014-12-10 4 M 0 15000 5.11 A 51248 D Common Stock 2014-12-10 4 S 0 15000 35.7864 D 36248 D Common Stock 2014-12-10 4 M 0 12500 5.20 A 48748 D Common Stock 2014-12-10 4 S 0 12500 35.7864 D 36248 D Common Stock 2014-12-10 4 M 0 7500 14.22 A 43748 D Common Stock 2014-12-10 4 S 0 7500 35.7864 D 36248 D Common Stock 2014-12-10 4 M 0 15000 6.74 A 51248 D Common Stock 2014-12-10 4 S 0 15000 35.7864 D 36248 D Common Stock 2014-12-10 4 M 0 30000 6.92 A 66248 D Common Stock 2014-12-10 4 S 0 30000 35.7864 D 36248 D Common Stock 2014-12-10 4 M 0 1500 7.55 A 37748 D Common Stock 2014-12-10 4 S 0 1500 35.7864 D 36248 D Common Stock 2014-12-10 4 M 0 687 17.14 A 36935 D Common Stock 2014-12-10 4 S 0 687 35.7864 D 36248 D Common Stock 2014-12-10 4 M 0 3000 5.54 A 39248 D Common Stock 2014-12-10 4 S 0 3000 35.7864 D 36248 D Common Stock 2014-12-11 4 S 0 30801 34.9074 D 5447 D Common Stock 2014-12-11 4 S 0 120032 34.923 D 72384 I MCADAMS-SHAPIRO FAMILY TRUST DTD MAY 24, 1999 Common Stock 2014-12-12 4 S 0 44384 34.4465 D 28000 I MCADAMS-SHAPIRO FAMILY TRUST DTD MAY 24, 1999 Common Stock 2014-12-12 4 S 0 5447 34.48 D 0 D Stock Option (right to buy) 7.25 2014-12-10 4 M 0 3000 7.25 D 2018-01-25 Commmon Stock 3000 0 D Stock Option (right to buy) 0.60 2014-12-10 4 M 0 834 0.60 D 2015-10-26 Common Stock 834 0 D Stock Option (right to buy) 5.11 2014-12-10 4 M 0 15000 5.11 D 2023-06-06 Common Stock 15000 0 D Stock Option (right to buy) 5.20 2014-12-10 4 M 0 12500 5.20 D 2022-05-30 Common Stock 12500 0 D Stock Option (right to buy) 14.22 2014-12-10 4 M 0 7500 14.22 D 2024-05-29 Common Stock 7500 7500 D Stock Option (right to buy) 6.74 2014-12-10 4 M 0 15000 6.74 D 2021-05-25 Common Stock 15000 0 D Stock Option (right to buy) 6.92 2014-12-10 4 M 0 30000 6.92 D 2021-03-31 Common Stock 30000 0 D Stock Option (right to buy) 7.55 2014-12-10 4 M 0 1500 7.55 D 2020-08-20 Common Stock 1500 0 D Stock Option (right to buy) 17.14 2014-12-10 4 M 0 687 17.14 D 2024-02-07 Common Stock 687 813 D Stock Option (right to buy) 5.54 2014-12-10 4 M 0 3000 5.54 D 2022-01-12 Common Stock 3000 0 D The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $35.51 to $36.44, inclusive. The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $34.68 to $35.66, inclusive. This option is fully vested and exercisable. 1/12th of the shares subject to the option shall vest and become exercisable in a series of twelve equal monthly installments measured from May 29, 2014. 1/24th of the shares subject to the option shall vest and become exercisable on a monthly basis over the twenty-four months following the vesting commencement date of January 1, 2014. /s/ Lucy O. Day, as attorney-in-fact 2014-12-12